Characterization of tumor stem cell markers in squamous cell carcinoma of the oral cavity
PDF (Español (España))

Keywords

Squamous Cell Carcinoma of Head and Neck; Embryonal Carcinoma Stem Cells; Biomarkers; OCT4; SSEA-4; NANOG; TRA-1-60.

How to Cite

Campuzano-Castellanos, M., & García-Flórez, M. (2022). Characterization of tumor stem cell markers in squamous cell carcinoma of the oral cavity. Salud UIS, 55. https://doi.org/10.18273/saluduis.55.e:23020

Abstract

Introduction: Squamous cell carcinoma of the oral cavity is a pathology with poor survival rates. When it is not adequately treated, it is a tumor with high recurrence and resistance to treatment. According to new hypotheses, progenitor tumor cells, due to their properties of self-renewal, tumor initiation, migration, and metastasis, could be responsible for the maintenance and renewal of this tumor. However, there is still no consensus on their true participation, subsequent to difficult in their identification and  characterization. Materials and methods: In this research, 32 samples provided from patients diagnosis with squamous cell carcinoma of the oral cavity were used. To detect specific markers progenitor tumor cells were used immunofluorescence microscopy. Results: The cells markers OCT4, SSEA4, NANOG and TRA-1-60 were identified in the different stages of the tumor samples, all these findings suggest the role of tumor progenitor cells in the evolution of this pathology. Conclusions: The establishment and correct identification of the progenitor tumor cells provide new therapeutic options for the approach of this tumor seeking to improve the prognosis, survival rate and quality of life of the patient. 

https://doi.org/10.18273/saluduis.55.e:23020
PDF (Español (España))

References

Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol [Internet]. 2009; 45(4-5): 309-316. doi: https://doi.org/10.1016/j.oraloncology.2008.06.002

Noble AR, Greskovich JF, Han J, Reddy CA, Nwizu TI, Khan MF, et al. Risk factors associated with disease recurrence in patients with stage III/IV squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Anticancer Res. 2016; 36(2): 785-792.

Liao CT, Lin CY, Fan KH, Wang HM, Ng SH, Lee LY, et al. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease. Int J Radiat Oncol Biol Phys [Internet]. 2012; 82(1): 284-290. doi: https://doi.org/10.1016/j.ijrobp.2010.09.036

Kalyankrishna S, Grandis JR. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol [Internet]. 2006; 24(17): 2666-2672. doi: https://doi.org/10.1200/jco.2005.04.8306

Huang CG, Lee LA, Liao CT, Yen TC, Yang SL, Liu YC, et al. Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma. Oncotarget [Internet]. 2017; 8(21): 34820-34835. doi: https://doi.org/10.18632/oncotarget.16747

infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma. Oncotarget [Internet]. 2017; 8(21): 34820-34835. doi: https://doi.org/10.18632/oncotarget.16747

Lewis JS Jr, Smith MH, Wang X, Tong F, Mehrad M, Lang-Kuhs KA. Human papillomavirus-associated oral cavity squamous cell carcinoma: An entity with distinct morphologic and clinical features. Head Neck Pathol [Internet]. 2022. doi: https://doi.org/10.1007/s12105-022-01467-0

Nauta IH, Heideman DAM, Brink A, van der Steen B, Bloemena E, Koljenović S, et al. The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma. Int J Cancer [Internet]. 2021; 149(2): 420-430. doi: https://doi.org/10.1002/ijc.33514

Simple M, Suresh A, Das D, Kuriakose MA. Cancer stem cells and field cancerization of oral squamous cell carcinoma. Oral Oncol [Internet]. 2015; 51(7): 643-651. doi: https://doi.org/10.1016/j.oraloncology.2015.04.006

Bhutia SK, Naik PP, Praharaj PP, Panigrahi DP, Bhol CS, Mahapatra KK, et al. Identification and characterization of stem cells in oral cancer. Methods Mol Biol. [Internet]. 2019; 2002: 129-139. doi: https://doi.org/10.1007/7651_2018_184

Shin KH, Kim RH. An updated review of oral cancer stem cells and their stemness regulation. Crit Rev Oncog [Internet]. 2018; 23(3-4): 189-200. doi: https://doi.org/10.1615%2FCritRevOncog.2018027501

Patel SS, Shah KA, Shah MJ, Kothari KC, Rawal RM. Cancer stem cells and stemness markers in oral squamous cell carcinomas. Asian Pac J Cancer Prev [Internet]. 2014; 15(20): 8549-56. doi: https://doi.org/10.7314/apjcp.2014.15.20.8549

Wolmarans E, Boy SC, Nel S, Mercier AE, Pepper MS. Cancer stem cells in head and neck carcinomas: Identification and possible therapeutic implications. Adv Exp Med Biol [Internet]. 2018; 1083: 89-102. doi: https://doi.org/10.1007/5584_2017_116

Varun BR, Jayanthi P, Ramani P. Cancer stem cells: A comprehensive review on identification and therapeutic implications. J Oral Maxillofac Pathol [Internet]. 2020; 24(1): 190. doi: https://doi.org/10.4103/jomfp.jomfp_336_19

Beck B, Blanpain C. Unravelling cancer stem cell potential. Nat Rev Cancer [Internet]. 2013; 13(10): 727-738. doi: https://doi.org/10.1038/nrc3597

Chowdhury FN, Reisinger J, Gomez KE, Chimed TS, Thomas CM, Le PN, et al. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function. Oral Oncol [Internet]. 2019; 98: 118-124. doi: https://doi. org/10.1016/j.oraloncology.2019.09.011

Tsai LL, Yu CC, Chang YC, Yu CH, Chou MY. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. J Oral Pathol Med [Internet]. 2011; 40(8): 621-628. doi: https://doi.org/10.1111/j.1600-0714.2011.01015.x

Siu A, Lee C, Dang D, Lee C, Ramos DM. Stem cell markers as predictors of oral cancer invasion. Anticancer Res. 2012; 32(4): 1163-1166.

Kilmister EJ, Patel J, van Schaijik B, Bockett N, Brasch HD, Paterson E, et al. Cancer stem cell subpopulations are present within metastatic head and neck cutaneous squamous cell carcinoma. Front Oncol [Internet]. 2020; 10: 1091. doi: https://doi.org/10.3389/fonc.2020.01091

Ram R, Brasch HD, Dunne JC, Davis PF, Tan ST, Itinteang T. The identification of three cancer stem cell subpopulations within moderately differentiated lip squamous cell carcinoma. Front Surg [Internet]. 2017; 4: 12. doi: https://doi.org/10.3389/fsurg.2017.00012

Lee HJ, Kang YH, Lee JS, Byun JH, Kim UK, Jang SJ, et al. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma. BMC Oral Health [Internet]. 2015; 15(1): 153. doi: https://doi.org/10.1186/s12903-015-0120-9

Noto Z, Yoshida T, Okabe M, Koike C, Fathy M, Tsuno H, et al. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. Oral Oncol [Internet]. 2013; 49(8): 787-795. doi: https://doi.org/10.1016/j.oraloncology.2013.04.012

Mohiuddin IS, Wei SJ, Kang MH. Role of OCT4 in cancer stem-like cells and chemotherapy resistance. Biochim Biophys Acta Mol Basis Dis [Internet]. 2020; 1866(4): 165432. doi: https://doi.org/10.1016/j.bbadis.2019.03.005

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 Marisol Campuzano-Castellanos, Manuel García-Flórez

Downloads

Download data is not yet available.